These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29618137)

  • 1. Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.
    Taïeb D; Timmers H; Pacak K
    Horm Metab Res; 2019 Jul; 51(7):414-418. PubMed ID: 29618137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
    Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary paraganglioma-pheochromocytoma syndrome.
    Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
    Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
    [No Abstract]   [Full Text] [Related]  

  • 4. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
    Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
    Barletta JA; Hornick JL
    Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDH-related pheochromocytoma and paraganglioma.
    Kantorovich V; King KS; Pacak K
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):415-24. PubMed ID: 20833333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
    Marzola MC; Chondrogiannis S; Grassetto G; Rampin L; Maffione AM; Ferretti A; Opocher G; Schiavi F; Colletti PM; Rubello D
    Clin Nucl Med; 2014 Jan; 39(1):e53-8. PubMed ID: 23856824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
    J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Succinate dehydrogenase in cancer].
    Moog S; Favier J
    Med Sci (Paris); 2022 Mar; 38(3):255-262. PubMed ID: 35333162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
    Oudijk L; Gaal J; de Krijger RR
    Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytomas: from genetic diversity to new paradigms.
    Qin Y; Buddavarapu K; Dahia PL
    Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect.
    Moosavi B; Zhu XL; Yang WC; Yang GF
    Eur J Cell Biol; 2020 Jan; 99(1):151057. PubMed ID: 31810635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma.
    Nakamura E; Kaelin WG
    Endocr Pathol; 2006; 17(2):97-106. PubMed ID: 17159241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
    Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
    Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 19. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
    Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
    J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency.
    Al Khazal F; Kang S; Nelson Holte M; Choi DS; Singh R; Ortega-Sáenz P; López-Barneo J; Maher LJ
    FASEB J; 2021 Feb; 35(2):e21227. PubMed ID: 33247500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.